PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Company ReportsAveritas Pharma
Averitas Pharma
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
No data
Company Revenue
No data
Revenue by Drug
Loading
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
QutenzaCapsaicin2009-11-162023-2030
Neuralgia
,
Diabetic neuropathies
,
Herpes zoster
MovantikNaloxegol oxalate2014-09-162024-2032
Constipation
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Capsaicin
postherpetic neuralgia
,
diabetic neuropathies
,
low back pain
,
back pain
,
radiculopathy
Nepidermin
melanoma
,
lymphoma
,
sezary syndrome
,
mycosis fungoides
,
t-cell lymphoma cutaneous
,
healthy volunteers/patients
,
triple negative breast neoplasms
,
pancreatic neoplasms
,
adenocarcinoma of lung
,
bronchiolo-alveolar adenocarcinoma
,
stomach neoplasms
,
head and neck neoplasms
,
squamous cell carcinoma of head and neck
,
b-cell lymphoma marginal zone
,
male breast neoplasms
,
non-small-cell lung carcinoma
,
type 2 diabetes mellitus
,
diabetes mellitus
,
lung neoplasms
,
heart failure
,
recurrence
,
colorectal neoplasms
,
ovarian neoplasms
,
fallopian tube neoplasms
,
peritoneal neoplasms
,
hyperglycemia
,
hypogonadism
,
female genital neoplasms
,
pelvic neoplasms
,
fibromyalgia
,
small cell carcinoma
,
small cell lung carcinoma
,
depression
,
depressive disorder
,
rheumatoid arthritis
,
obesity
,
unknown primary neoplasms
,
hypertension
,
renal insufficiency
,
cholangiocarcinoma
,
gallbladder neoplasms
,
breast neoplasms
,
neoplasms
,
neoplasm metastasis
,
major depressive disorder
,
hyperkinesis
,
dyslexia
,
attention deficit disorder with hyperactivity
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use